Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation
Nephron · 2023 · 147 (Suppl. 1) · 9-13
DOI: 10.1159/000530341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephron, online erschienen am 24.03.2023. Verfasst von Mayuko Kawabe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, mayuko@jikei.ac.jp. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Kidney Transplantation, Kidney Failure, Chronic. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
IgA nephropathy (IgAN) is the most common form of glomerulonephritis worldwide. IgAN progresses to end-stage kidney disease in 20–40% of patients within 20 years of diagnosis. Kidney transplantation is the most effective option for patients with end-stage kidney disease caused by IgAN, but recurrence can occur in the transplanted kidney. The IgAN recurrence rate varies from 1% to 10% per year and varies according to the follow-up period, diagnostic modality, and biopsy criteria. Of note, studies based on protocol biopsies have reported a higher incidence of recurrence, which also occurred earlier after transplantation. In addition, recent data show that recurrence of IgAN is a more significant cause of allograft failure than previously believed. Little is known about the pathophysiology of IgAN recurrence, but several potential biomarkers have been investigated. Among them, galactose-deficient IgA1 (Gd-IgA1), IgG anti-Gd-IgA1 antibodies, and soluble CD89 could play a pivotal role in disease activity. This review aims to describe the current status of recurrent IgAN, including the incidence, clinical characteristics, risk factors, and future perspectives, with a focus on the available therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan, mayuko@jikei.ac.jp.
- Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Zitieren
APA
Kawabe, M., & Yamamoto, I. (2023). Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation. Nephron, 147(Suppl. 1), 9-13. https://doi.org/10.1159/000530341
Vancouver
Kawabe M, Yamamoto I. Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation. Nephron. 2023;147(Suppl. 1):9-13. doi:10.1159/000530341
BibTeX
@article{Kawabe2023,
author = {Kawabe, Mayuko and Yamamoto, Izumi},
title = {Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation},
journal = {Nephron},
year = {2023},
volume = {147},
number = {Suppl. 1},
pages = {9--13},
doi = {10.1159/000530341}
}
EUVIMED